Astrana Health annual gross margin
2010
2011
2012
2013
2015
2016
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
Astrana Health Gross Margin Growth & History (ASTH)
Astrana Health's gross margin was 10.73% for fiscal 2025.
View full Astrana Health company overviewAstrana Health annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 10.73% | −2.61 pp |
| 2024 | 2024-12-31 | 13.34% | −2.16 pp |
| 2023 | 2023-12-31 | 15.50% | −1.93 pp |
| 2022 | 2022-12-31 | 17.43% | −5.54 pp |
| 2021 | 2021-12-31 | 22.97% | +1.44 pp |
| 2020 | 2020-12-31 | 21.53% | +4.98 pp |
| 2019 | 2019-12-31 | 16.56% | −13.98 pp |
| 2018 | 2018-12-31 | 30.54% | +7.28 pp |
| 2017 · Dec 31 | 2017-12-31 | 23.26% | +6.54 pp |
| 2017 · Mar 31 | 2017-03-31 | 15.14% | −7.68 pp |
| 2016 · Dec 31 | 2016-12-31 | 16.72% | — |
| 2016 · Mar 31 | 2016-03-31 | 22.81% | −10.30 pp |
| 2015 | 2015-03-31 | 33.11% | — |
| 2013 | 2014-01-31 | 13.43% | −5.34 pp |
| 2012 | 2013-01-31 | 18.77% | −0.37 pp |
| 2011 | 2012-01-31 | 19.14% | +4.21 pp |
| 2010 | 2011-01-31 | 14.93% | — |
Astrana Health quarterly gross margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q2.13
Q3.13
Q3.13
Q3.15
Q2.14
Q3.14
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q4.16
Q4.17
Q1.18
Q2.18
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 10.70% | −1.21 pp |
| Q1 2026 | 2026-03-31 | 10.96% | −0.54 pp |
| Q4 2025 | 2025-12-31 | 10.00% | +2.41 pp |
| Q3 2025 | 2025-09-30 | 10.17% | −5.19 pp |
| Q2 2025 | 2025-06-30 | 11.91% | −3.20 pp |
| Q1 2025 | 2025-03-31 | 11.50% | −6.79 pp |
| Q4 2024 | 2024-12-31 | 7.59% | −3.45 pp |
| Q3 2024 | 2024-09-30 | 15.35% | −5.56 pp |
| Q2 2024 | 2024-06-30 | 15.11% | −0.78 pp |
| Q1 2024 | 2024-03-31 | 18.29% | +4.10 pp |
| Q4 2023 | 2023-12-31 | 11.04% | −2.92 pp |
| Q3 2023 | 2023-09-30 | 20.91% | −3.14 pp |
| Q2 2023 | 2023-06-30 | 15.89% | +1.20 pp |
| Q1 2023 | 2023-03-31 | 14.19% | −1.97 pp |
| Q4 2022 | 2022-12-31 | 13.97% | +2.04 pp |
| Q3 2022 | 2022-09-30 | 24.05% | −11.02 pp |
| Q2 2022 | 2022-06-30 | 14.69% | −7.75 pp |
| Q1 2022 | 2022-03-31 | 16.15% | −3.98 pp |
| Q4 2021 | 2021-12-31 | 11.92% | −10.52 pp |
| Q3 2021 | 2021-09-30 | 35.07% | +2.70 pp |
| Q2 2021 | 2021-06-30 | 22.45% | +4.83 pp |
| Q1 2021 | 2021-03-31 | 20.13% | +7.47 pp |
| Q4 2020 | 2020-12-31 | 22.44% | +7.41 pp |
| Q3 2020 | 2020-09-30 | 32.37% | +16.39 pp |
| Q2 2020 | 2020-06-30 | 17.61% | −4.45 pp |
| Q1 2020 | 2020-03-31 | 12.66% | −0.21 pp |
| Q4 2019 | 2019-12-31 | 15.03% | −9.40 pp |
| Q3 2019 | 2019-09-30 | 15.97% | −26.29 pp |
| Q2 2019 | 2019-06-30 | 22.06% | +3.34 pp |
| Q1 2019 | 2019-03-31 | 12.87% | −18.85 pp |
| Q4 2018 | 2018-12-31 | 24.44% | +11.33 pp |
| Q3 2018 | 2018-09-30 | 42.26% | +10.97 pp |
| Q2 2018 · Jun 30 | 2018-06-30 | 18.72% | +0.71 pp |
| Q1 2018 · Mar 31 | 2018-03-31 | 31.72% | +1.57 pp |
| Q4 2017 | 2017-12-31 | 13.11% | −5.77 pp |
| Q2 2018 · Sep 30 | 2017-09-30 | 31.29% | +14.53 pp |
| Q1 2018 · Jun 30 | 2017-06-30 | 18.00% | −0.09 pp |
| Q4 2017 | 2017-03-31 | 30.15% | +12.29 pp |
| Q4 2016 | 2016-12-31 | 18.88% | −1.73 pp |
| Q2 2017 | 2016-09-30 | 16.76% | −10.55 pp |
| Q1 2017 | 2016-06-30 | 18.10% | −7.74 pp |
| Q4 2016 | 2016-03-31 | 17.86% | −13.76 pp |
| Q3 2016 | 2015-12-31 | 20.60% | +0.29 pp |
| Q2 2016 | 2015-09-30 | 27.31% | −19.87 pp |
| Q1 2016 | 2015-06-30 | 25.84% | +5.45 pp |
| Q4 2015 | 2015-03-31 | 31.62% | — |
| Q3 2015 · Dec 31 | 2014-12-31 | 20.31% | −7.96 pp |
| Q3 2014 | 2014-09-30 | 47.18% | +36.73 pp |
| Q2 2014 | 2014-06-30 | 20.38% | +14.39 pp |
| Q3 2015 · Dec 31 | 2013-12-31 | 28.27% | — |
| Q3 2013 · Oct 31 | 2013-10-31 | 17.83% | +9.38 pp |
| Q3 2013 · Sep 30 | 2013-09-30 | 10.45% | — |
| Q2 2013 · Jul 31 | 2013-07-31 | 8.74% | −18.16 pp |
| Q2 2013 · Jun 30 | 2013-06-30 | 6.00% | — |
| Q1 2013 | 2013-04-30 | 23.95% | +5.38 pp |
| Q4 2012 | 2013-01-31 | 21.62% | −4.07 pp |
| Q3 2012 | 2012-10-31 | 8.46% | −14.93 pp |
| Q2 2012 | 2012-07-31 | 26.90% | +12.79 pp |
| Q1 2012 | 2012-04-30 | 18.58% | +9.71 pp |
| Q4 2011 | 2012-01-31 | 25.69% | — |
| Q3 2011 | 2011-10-31 | 23.38% | +8.57 pp |
| Q2 2011 | 2011-07-31 | 14.11% | −2.72 pp |
| Q1 2011 | 2011-04-30 | 8.87% | — |
| Q3 2010 | 2010-10-31 | 14.81% | — |
| Q2 2010 | 2010-07-31 | 16.83% | — |
Astrana Health gross margin trends
Over the last five fiscal years, Astrana Health's gross margin decreased from 21.53% to 10.73%, a change of −10.80 percentage points. The latest reported quarter, Q2 2026, shows 10.70%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Astrana Health source filings ↗